A Clinician's Perspective on Incretin-Based Therapies
Started 6/21/2013 by John Parkinson
John ParkinsonORIGINAL POSTER
John Parkinson - Posted 6/21/2013
DiabetesCare.net's Dr. Sam Grossman weighs in on the benefits, the mechanisms of action, and the pancreatic health risks associated with GLP-1 analogs and DPP-4 inhibitors. Read the story here.
